a company which engages in development of novel recombinant vaccines
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBSIX | 40.70 | -0.14 | -0.34% |
Franklin Mutual U.S. Mid Cap Value R6 | |||
PIXEX | 25.63 | -0.09 | -0.35% |
Principal Glb Emerging Markets R1 | |||
IGFFX | 36.56 | -0.20 | -0.54% |
American Funds Intl Gr and Inc F2 | |||
SNIEX | 21.55 | -0.12 | -0.55% |
BNY Mellon International Equity I | |||
LEQCX | 11.43 | -0.09 | -0.78% |
LoCorr Dynamic Opportunity C |
A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with THRD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then THRD could also see price increases.
Ticker / NAME | Correlation To NVAX | 1D Price Change % | ||
---|---|---|---|---|
NVAX | 100% | +1.39% | ||
THRD - NVAX | 42% Loosely correlated | -5.81% | ||
ITOS - NVAX | 39% Loosely correlated | -2.72% | ||
ADMA - NVAX | 36% Loosely correlated | -5.74% | ||
RXRX - NVAX | 33% Loosely correlated | -10.64% | ||
EDIT - NVAX | 33% Poorly correlated | -3.97% | ||
More |